Sponsor

Rising Tide Foundation

Clinical research sponsor

Published trials10
Recruiting shown5
Roles1
SourceClinicalTrials.gov

Clinical trials

10 shown
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY TrialNCT06042569 · collaborator · 2024-09-16
RECRUITING
Prevention of Frailty With Fisetin and Exercise in Breast Cancer SurvivorsNCT06113016 · collaborator · 2024-07-23
RECRUITING
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer SurgeryNCT05766891 · collaborator · 2023-10-12
RECRUITING
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated LymphedemaNCT05890677 · collaborator · 2023-07-14
RECRUITING
TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate CancerNCT05582772 · collaborator · 2023-05-23
RECRUITING
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate CancerNCT05653063 · collaborator · 2023-12-07
ACTIVE_NOT_RECRUITING
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast CancerNCT02907918 · collaborator · 2017-06-30
TERMINATED
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCISNCT02926911 · collaborator · 2017-02-22
ACTIVE_NOT_RECRUITING
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine TherapyNCT02204098 · collaborator · 2015-01-07
ACTIVE_NOT_RECRUITING
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.NCT01928576 · collaborator · 2013-11-06
COMPLETED

Sponsor roles

collaborator10

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.